These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 15257547)

  • 1. 15-Lipoxygenase-2 expression in benign and neoplastic lung: an immunohistochemical study and correlation with tumor grade and proliferation.
    Gonzalez AL; Roberts RL; Massion PP; Olson SJ; Shyr Y; Shappell SB
    Hum Pathol; 2004 Jul; 35(7):840-9. PubMed ID: 15257547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced 15-lipoxygenase-2 immunostaining in prostate adenocarcinoma: correlation with grade and expression in high-grade prostatic intraepithelial neoplasia.
    Jack GS; Brash AR; Olson SJ; Manning S; Coffey CS; Smith JA; Shappell SB
    Hum Pathol; 2000 Sep; 31(9):1146-54. PubMed ID: 11014584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 15S-Hydroxyeicosatetraenoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells.
    Shappell SB; Gupta RA; Manning S; Whitehead R; Boeglin WE; Schneider C; Case T; Price J; Jack GS; Wheeler TM; Matusik RJ; Brash AR; Dubois RN
    Cancer Res; 2001 Jan; 61(2):497-503. PubMed ID: 11212240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 15-lipoxygenase-2 (15-LOX-2) is expressed in benign prostatic epithelium and reduced in prostate adenocarcinoma.
    Shappell SB; Boeglin WE; Olson SJ; Kasper S; Brash AR
    Am J Pathol; 1999 Jul; 155(1):235-45. PubMed ID: 10393855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 15-Lipoxygenase-2 expression in benign and neoplastic sebaceous glands and other cutaneous adnexa.
    Shappell SB; Keeney DS; Zhang J; Page R; Olson SJ; Brash AR
    J Invest Dermatol; 2001 Jul; 117(1):36-43. PubMed ID: 11442747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antineoplastic effects of 15(S)-hydroxyeicosatetraenoic acid and 13-S-hydroxyoctadecadienoic acid in non-small cell lung cancer.
    Li MY; Yuan HL; Ko FW; Wu B; Long X; Du J; Wu J; Ng CS; Wan IY; Mok TS; Hui DS; Underwood MJ; Chen GG
    Cancer; 2015 Sep; 121 Suppl 17():3130-45. PubMed ID: 26331820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced expression of 15-lipoxygenase 2 in human head and neck carcinomas.
    Wang D; Chen S; Feng Y; Yang Q; Campbell BH; Tang X; Campbell WB
    Tumour Biol; 2006; 27(5):261-73. PubMed ID: 16874012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 15-Lipoxygenases and its metabolites 15(S)-HETE and 13(S)-HODE in the development of non-small cell lung cancer.
    Yuan H; Li MY; Ma LT; Hsin MK; Mok TS; Underwood MJ; Chen GG
    Thorax; 2010 Apr; 65(4):321-6. PubMed ID: 20388757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 15-Lipoxygenase-2 gene regulation by its product 15-(S)-hydroxyeicosatetraenoic acid through a negative feedback mechanism that involves peroxisome proliferator-activated receptor gamma.
    Subbarayan V; Krieg P; Hsi LC; Kim J; Yang P; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
    Oncogene; 2006 Sep; 25(44):6015-25. PubMed ID: 16682954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opposing effects of 15-lipoxygenase-1 and -2 metabolites on MAPK signaling in prostate. Alteration in peroxisome proliferator-activated receptor gamma.
    Hsi LC; Wilson LC; Eling TE
    J Biol Chem; 2002 Oct; 277(43):40549-56. PubMed ID: 12189136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of PPARγ by 12/15-lipoxygenase during cerebral ischemia-reperfusion injury.
    Han J; Sun L; Xu Y; Liang H; Cheng Y
    Int J Mol Med; 2015 Jan; 35(1):195-201. PubMed ID: 25395029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
    Hong SH; Avis I; Vos MD; Martínez A; Treston AM; Mulshine JL
    Cancer Res; 1999 May; 59(9):2223-8. PubMed ID: 10232612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic contribution of ubiquitous 15-lipoxygenase-1 expression loss in cancer cells to terminal cell differentiation evasion.
    Moussalli MJ; Wu Y; Zuo X; Yang XL; Wistuba II; Raso MG; Morris JS; Bowser JL; Minna JD; Lotan R; Shureiqi I
    Cancer Prev Res (Phila); 2011 Dec; 4(12):1961-72. PubMed ID: 21881028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inverse relationship between 15-lipoxygenase-2 and PPAR-gamma gene expression in normal epithelia compared with tumor epithelia.
    Subbarayan V; Xu XC; Kim J; Yang P; Hoque A; Sabichi AL; Llansa N; Mendoza G; Logothetis CJ; Newman RA; Lippman SM; Menter DG
    Neoplasia; 2005 Mar; 7(3):280-93. PubMed ID: 15799828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations of lysyl oxidase with MMP2/MMP9 expression and its prognostic value in non-small cell lung cancer.
    Liu J; Ping W; Zu Y; Sun W
    Int J Clin Exp Pathol; 2014; 7(9):6040-7. PubMed ID: 25337249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A word of caution regarding napsin A expression in squamous cell carcinomas of the lung.
    Ordóñez NG
    Am J Surg Pathol; 2012 Mar; 36(3):396-401. PubMed ID: 22198009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 15-Lipoxygenase-2/15(S)-hydroxyeicosatetraenoic acid regulates cell proliferation and metastasis via the STAT3 pathway in lung adenocarcinoma.
    Yang L; Ma C; Zhang L; Zhang M; Li F; Zhang C; Yu X; Wang X; He S; Zhu D; Song Y
    Prostaglandins Other Lipid Mediat; 2018 Sep; 138():31-40. PubMed ID: 30110652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in lipoxygenase and cyclooxygenase-2 catalytic activity and mRNA expression in prostate carcinoma.
    Shappell SB; Manning S; Boeglin WE; Guan YF; Roberts RL; Davis L; Olson SJ; Jack GS; Coffey CS; Wheeler TM; Breyer MD; Brash AR
    Neoplasia; 2001; 3(4):287-303. PubMed ID: 11571629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyroid transcription factor-1 (TTF-1) expression in human lung carcinomas: its prognostic implication and relationship with wxpressions of p53 and Ki-67 proteins.
    Myong NH
    J Korean Med Sci; 2003 Aug; 18(4):494-500. PubMed ID: 12923324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.